Brokerage firm Craig-Hallum Downgrades its rating on RTI Surgical Inc(NASDAQ:RTIX). The shares have been rated Hold. Previously, the analysts had a Buy rating on the shares. The rating by Craig-Hallum was issued on Jul 28, 2016.
RTI Surgical Inc (RTIX) shares turned negative on Thursdays trading session with the shares closing down -0.06 points or -1.90% at a volume of 1,79,841. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $3.19. The peak price level was also seen at $3.19 while the days lowest was $3.1. Finally the shares closed at $3.1. The 52-week high of the shares is $7.27 while the 52-week low is $2.81. According to the latest information available, the market cap of the company is $180 M.
RTI Surgical Inc(RTIX) last announced its earnings results on Apr 28, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $67.35M. Analysts had an estimated revenue of $65.68M. Earnings per share were $0.03. Analysts had estimated an EPS of $0.03.
RTI Surgical Inc. produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. The Company uses natural tissues metals and synthetics process to produce its products. The Company processes donated human musculoskeletal and other tissue including bone cartilage tendon ligament fascia lata pericardium sclera and dermal tissue and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE TUTOPLAST and CANCELLE SP sterilization processes and manufacture metal and synthetic implants for distribution to hospitals and surgeons. The Company’s business has six categories: spine sports medicine ortho fixation bone graft substitutes and general orthopedic (BGS and general orthopedic) surgical specialties and dental. The Company distributes its implants and services in all 50 states and in over 45 countries worldwide.